ArticleClinical epigenetics2019

Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.

Zachary L Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.